← All trials
NCT05570669
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 25, 2021
- Primary completion
- Dec 28, 2021
- Completion date
- Dec 28, 2021
- First posted
- Oct 6, 2022
- Last posted
- Oct 6, 2022
- Enrollment
- 321
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Societa Italiana di Endoscopia DigestivaLead sponsor
- Azienda Ospedaliera Specializzata in Gastroenterologia IRCCS Saverio de BellisCollaborator
- University of Roma La SapienzaCollaborator
- University of Naples Frederico IICollaborator
- University of BolognaCollaborator
- Societa Italiana di Endoscopia DigestivaStudy chair
- Societa Italiana di Endoscopia DigestivaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.